Press release
Hematopoietic Stem Cell Transplantation Market 2024-2033: Size, Share & Competitive Landscape
The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, market expansion and accessibility. Major trends in the forecast period include advancements in transplant techniques, expansion of indications, emerging cellular therapies, donor diversification, precision medicine approach.
Market Overview -
Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient's damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient's body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp
Rising Blood Cancer Incidence Fuels Growth In The Hematopoietic Stem Cell Transplantation Market
The increased frequency of blood cancer is expected to propel the growth of the hematopoietic stem cell transplantation market. A group of malignancies that impact the development and operation of blood cells are referred to as blood cancers. Leukemia, lymphoma, and myeloma are the three main types of blood cancer. By replacing stem cells and bone marrow cells that have been killed by the malignancy, hematopoietic stem cell transplantation is generally used to treat blood cancer. These new stem cells can then move to the bone marrow and start creating new blood cells. So, these factors boost the hematopoietic stem cell transplantation market. For instance, in August 2022, according to the report shared by Blood Cancer UK, a UK-based non-profit organization, there are 41,000 blood cancer cases identified each year, making blood cancer the sixth most prevalent malignancy in the UK. Blood cancer, which affects one in 16 men and one in 22 women at some time in their lives, will afflict around 250,000 people in the UK in 2022. Additionally, more than 500 children under the age of 15 are affected by blood cancer each year. 400 of them have pediatric leukemia, and 100 of them have lymphoma. Therefore, the increased frequency of blood cancer drives the hematopoietic stem cell transplantation market.
Competitive Landscape -
Major companies operating in the hematopoietic stem cell transplantation market report are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., NuVasive Inc., RTI Surgical Ltd., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd., 3D Biomatrix, Worthington Biochemical
Product Approvals Drive Advancements In The Hematopoietic Stem Cell Transplantation Market
Product approvals are a key trend gaining popularity in the hematopoietic stem cell transplantation market. Major companies operating in the hematopoietic stem cell transplantation market are adopting product approvals to sustain their position in the market. For instance, in April 2022, Priothera Ltd., an Ireland-based late-clinical stage biotechnology company, received the United States Food and Drug Administration (FDA) clearance of an investigational new drug (IND) to begin an allogeneic hematopoietic stem cell transplant (HSCT) Phase IIb/III research study with mocravimod in patients with acute myeloid leukemia (AML). Mocravimod is a synthetic sphingosine 1-phosphate receptor (S1PR) modulator, also known as KRP203. Phase I and Phase II trials have evaluated the safety, tolerability, and effectiveness of this unique experimental medication for a number of autoimmune diseases.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report
Key Segments -
The hematopoietic stem cell transplantation market covered in this report is segmented -
1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematopoietic Stem Cell Transplantation Market 2024-2033: Size, Share & Competitive Landscape here
News-ID: 3477769 • Views: …
More Releases from The Business research company
Navigating Progress: Commercial Radars Lead Global Security in 2024- Explores ho …
The commercial radars market size has grown strongly in recent years. It will grow from $5.81 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to military and defense applications, aviation and air traffic control, maritime and ship navigation, weather forecasting, security and surveillance.
The commercial radars market size is expected to…
Navigating Progress: Commercial Radars Lead Global Security in 2024- Explores ho …
The commercial radars market size has grown strongly in recent years. It will grow from $5.81 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to military and defense applications, aviation and air traffic control, maritime and ship navigation, weather forecasting, security and surveillance.
The commercial radars market size is expected to…
Navigating Progress: Commercial Radars Lead Global Security in 2024- Explores ho …
The commercial radars market size has grown strongly in recent years. It will grow from $5.81 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to military and defense applications, aviation and air traffic control, maritime and ship navigation, weather forecasting, security and surveillance.
The commercial radars market size is expected to…
Connected Worlds: Cellular Telephones Redefine Communication in 2024- Discusses …
The cellular telephones market size has grown strongly in recent years. It will grow from $419.79 billion in 2023 to $453.05 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing consumer demand, expanding global connectivity, mobile apps and ecosystems.
The cellular telephones market size is expected to see strong growth in the next few years.…
More Releases for Stem
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues.
Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html
In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large…
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports.
Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process…
Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
MarketResearchReports.Biz adds “Global Stem Cell Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Stem Cell and the growth estimates for the forecasted period.
Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a…
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that…
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports.
In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between…
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports.
In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a…
